tailieunhanh - Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay

Lesinurad is an oral inhibitor of urate-anion exchanger transporter 1 and has been approved by the US Food and Drug Administration for combination therapy with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with refractory gout. | Determination of lesinurad in rat plasma by a UHPLC MS MS assay

TỪ KHÓA LIÊN QUAN